Free Trial

Thames Ventures VCT 2 Healthcare Shs (TV2H) Competitors

TV2H vs. SDV, VLE, ALAI, OFG, CBA, JRS, ALM, VNC, HDIV, and GV2O

Should you be buying Thames Ventures VCT 2 Healthcare Shs stock or one of its competitors? The main competitors of Thames Ventures VCT 2 Healthcare Shs include Chelverton UK Dividend Trust (SDV), Volvere (VLE), abrdn Latin American Income Fund (ALAI), Octopus Future Generations VCT (OFG), Ceiba Investments (CBA), JPMorgan Russian Securities (JRS), Allied Minds (ALM), Ventus VCT 2 C (VNC), Henderson Diversified Income (HDIV), and Gresham House Renewable Energy VCT 2 (GV2O). These companies are all part of the "asset management" industry.

Thames Ventures VCT 2 Healthcare Shs vs.

Chelverton UK Dividend Trust (LON:SDV) and Thames Ventures VCT 2 Healthcare Shs (LON:TV2H) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

In the previous week, Chelverton UK Dividend Trust's average media sentiment score of 0.00 equaled Thames Ventures VCT 2 Healthcare Shs'average media sentiment score.

Company Overall Sentiment
Chelverton UK Dividend Trust Neutral
Thames Ventures VCT 2 Healthcare Shs Neutral

5.7% of Chelverton UK Dividend Trust shares are held by institutional investors. 36.9% of Chelverton UK Dividend Trust shares are held by company insiders. Comparatively, 0.1% of Thames Ventures VCT 2 Healthcare Shs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Chelverton UK Dividend Trust received 62 more outperform votes than Thames Ventures VCT 2 Healthcare Shs when rated by MarketBeat users.

CompanyUnderperformOutperform
Chelverton UK Dividend TrustOutperform Votes
62
54.39%
Underperform Votes
52
45.61%
Thames Ventures VCT 2 Healthcare ShsN/AN/A

Thames Ventures VCT 2 Healthcare Shs has lower revenue, but higher earnings than Chelverton UK Dividend Trust.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chelverton UK Dividend Trust£1.63M21.60-£2.60MN/AN/A
Thames Ventures VCT 2 Healthcare ShsN/AN/AN/A-£0.02N/A

Thames Ventures VCT 2 Healthcare Shs has a net margin of 0.00% compared to Chelverton UK Dividend Trust's net margin of -0.25%. Thames Ventures VCT 2 Healthcare Shs' return on equity of 0.00% beat Chelverton UK Dividend Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Chelverton UK Dividend Trust-0.25% -0.01% 0.90%
Thames Ventures VCT 2 Healthcare Shs N/A N/A N/A

Given Thames Ventures VCT 2 Healthcare Shs' higher probable upside, analysts clearly believe Thames Ventures VCT 2 Healthcare Shs is more favorable than Chelverton UK Dividend Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chelverton UK Dividend Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Thames Ventures VCT 2 Healthcare Shs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Chelverton UK Dividend Trust pays an annual dividend of GBX 13 per share and has a dividend yield of 8.0%. Thames Ventures VCT 2 Healthcare Shs pays an annual dividend of GBX 1 per share. Thames Ventures VCT 2 Healthcare Shs pays out -5,000.0% of its earnings in the form of a dividend.

Summary

Chelverton UK Dividend Trust beats Thames Ventures VCT 2 Healthcare Shs on 7 of the 11 factors compared between the two stocks.

Get Thames Ventures VCT 2 Healthcare Shs News Delivered to You Automatically

Sign up to receive the latest news and ratings for TV2H and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TV2H vs. The Competition

MetricThames Ventures VCT 2 Healthcare ShsAsset Management IndustryFinancial SectorLON Exchange
Market Cap£8.83M£771.91M£3.15B£1.40B
Dividend Yield2.29%13.42%4.61%11.82%
P/E Ratio-1,875.00750.34431.191,566.47
Price / SalesN/A13,489.962,979.52210,811.83
Price / CashN/A53.5448.0026.69
Price / BookN/A1.692.272.86
Net IncomeN/A£57.11M£394.92M£153.77M
7 Day PerformanceN/A0.02%6.18%4.76%
1 Month PerformanceN/A-0.87%-0.03%3.35%
1 Year PerformanceN/A11.94%16.22%107.00%

Thames Ventures VCT 2 Healthcare Shs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TV2H
Thames Ventures VCT 2 Healthcare Shs
N/AN/AN/AN/A£8.83MN/A-1,875.00N/AGap Up
SDV
Chelverton UK Dividend Trust
N/AGBX 161.50
-1.5%
N/A+15.3%£35.21M£1.63M656.31N/A
VLE
Volvere
N/AGBX 1,585
flat
N/A+37.8%£35.03M£46.06M1,209.92226
ALAI
abrdn Latin American Income Fund
N/AGBX 60.25
flat
N/AN/A£34.41M£2.70M1,506.25N/A
OFG
Octopus Future Generations VCT
N/AGBX 82.50
flat
N/AN/A£33.93MN/A0.002,250High Trading Volume
CBA
Ceiba Investments
N/AGBX 24.50
flat
N/AN/A£33.73M£19.30M-612.50N/A
JRS
JPMorgan Russian Securities
N/AGBX 83
-0.4%
N/A+0.0%£33.56M£-259,516,000.0021.78N/APositive News
ALM
Allied Minds
N/AGBX 13.85
+30.0%
N/AN/A£33.54M£2.86M-2.6631Gap Down
High Trading Volume
VNC
Ventus VCT 2 C
N/AGBX 86.50
+9,900.0%
N/A+0.0%£32.58M£9.47M4.08N/AGap Up
High Trading Volume
HDIV
Henderson Diversified Income
N/AGBX 17.46
+0.5%
N/A+1.7%£31.79M£-30,190,000.00-436.50N/ADividend Cut
GV2O
Gresham House Renewable Energy VCT 2
N/AGBX 44.40
flat
N/AN/A£29.13MN/A0.00N/A

Related Companies and Tools


This page (LON:TV2H) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners